⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 4, 2021Expert Review of VaccinesOpen Access

Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines

Piyali Mukherjee Essè Ifèbi Hervé Akpo Anastasia Kuznetsova Markus Knuf Sven‐Arne Silfverdal Pope Kosalaraksa Attila Mihalyi

View Full Paper

Ask AI

Bookmark

Share

Abstract

: ORs of analyzed local and systemic solicited adverse reactions after primary vaccination with DT3aP-HBV-IPV-Hib appear to be slightly lower than with DT2aP-HBV-IPV-Hib.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mukherjee et al. (2021) studied this question.

synapsesocial.com/papers/6a1d39b47f448865515e0301 https://doi.org/10.1080/14760584.2021.1892493

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Vaccine strategies: Optimising outcomesReview · 2016 · 150 citations
2Review of 8 years of experience with Infanrix hexa™ (DTPa–HBV–IPV/Hib hexavalent vaccine)Clinical Trial · 2009 · 68 citations
3Combination VaccinesReview · 2011 · 129 citations
4The value of childhood combination vaccines: From beliefs to evidenceReview · 2015 · 156 citations
5Effect of combination vaccines on completion and compliance of childhood vaccinations in the United StatesCross-Sectional Study · 2017 · 54 citations

A systematic review of factors affecting vaccine uptake in young children2017
The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations2017
Safety profile of <i>Infanrix hexa</i> – 17 years of GSK’s passive post-marketing surveillance2020
Safety and immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy Chinese adults: two single-center, randomized, double-blind Phase 1 and Phase 2 trialsExpert Review of Vaccines · 2026
The socioeconomic value of adult respiratory vaccination in Australia: a benefit-cost analysisExpert Review of Vaccines · 2026

More from Expert Review of Vaccines

More from Johannes Gutenberg University Mainz

More from Umeå University

More from University Medical Center of the Johannes Gutenberg University Mainz

More from Khon Kaen University

More from GlaxoSmithKline (Belgium)

More from Helios Dr. Horst Schmidt Kliniken Wiesbaden